These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38741835)

  • 41. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.
    Tolliver BK; Desantis SM; Brown DG; Prisciandaro JJ; Brady KT
    Bipolar Disord; 2012 Feb; 14(1):54-63. PubMed ID: 22329472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Daily associations between alcohol and sweets craving and consumption in early AUD recovery: Results from an ecological momentary assessment study.
    Abrantes AM; Kunicki Z; Braun T; Miranda R; Blevins CE; Brick L; Thomas G; Marsh E; Feltus S; Stein MD
    J Subst Abuse Treat; 2022 Jan; 132():108614. PubMed ID: 34493429
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphin.
    Hammarberg A; Nylander I; Zhou Q; Jayaram-Lindström N; Reid MS; Franck J
    Brain Res; 2009 Dec; 1305 Suppl():S2-6. PubMed ID: 19799882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alcohol craving and withdrawal at treatment entry prospectively predict alcohol use outcomes during outpatient treatment.
    Martins JS; Fogelman N; Wemm S; Hwang S; Sinha R
    Drug Alcohol Depend; 2022 Feb; 231():109253. PubMed ID: 34998258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence.
    Sass H; Soyka M; Mann K; Zieglgänsberger W
    Arch Gen Psychiatry; 1996 Aug; 53(8):673-80. PubMed ID: 8694680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
    Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy.
    Minozzi S; Ambrosi L; Saulle R; Uhm SS; Terplan M; Sinclair JM; Agabio R
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD015042. PubMed ID: 38682758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
    Rose AK; Jones A
    Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Multiple Detoxifications on Withdrawal Symptoms, Psychiatric Distress and Alcohol-Craving in Patients with an Alcohol Use Disorder.
    Ooms M; Roozen HG; Willering JH; Zijlstra WP; de Waart R; Goudriaan AE
    Behav Med; 2021; 47(4):296-310. PubMed ID: 32396039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Baclofen for alcohol withdrawal.
    Liu J; Wang LN
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31689723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
    Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Smartphone Physical Activity App for Patients in Alcohol Treatment: Single-Arm Feasibility Trial.
    Abrantes AM; Meshesha LZ; E Blevins C; Battle CL; Lindsay C; Marsh E; Feltus S; Buman M; Agu E; Stein M
    JMIR Form Res; 2022 Oct; 6(10):e35926. PubMed ID: 36260381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
    Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
    Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sleep and the Pharmacotherapy of Alcohol Use Disorder: Unfortunate Bedfellows. A Systematic Review With Meta-Analysis.
    Panin F; Peana AT
    Front Pharmacol; 2019; 10():1164. PubMed ID: 31680952
    [No Abstract]   [Full Text] [Related]  

  • 55. Relationship between Craving and Early Relapse in Alcohol Dependence: A Short-Term Follow-up Study.
    Kharb R; Shekhawat LS; Beniwal RP; Bhatia T; Deshpande SN
    Indian J Psychol Med; 2018; 40(4):315-321. PubMed ID: 30093741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Craving as a DSM-5 Symptom of Alcohol Use Disorder in Non-Treatment Seekers.
    Hartwell EE; Ray LA
    Alcohol Alcohol; 2018 May; 53(3):235-240. PubMed ID: 29145640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Baclofen in alcohol use disorder: An analysis of the data provided by the French "Temporary Recommendation for Use" 2014-2017 cohort.
    de Beaurepaire R; Rolland B
    Front Psychiatry; 2022; 13():949750. PubMed ID: 36311508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
    Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of 10 add-on HF-rTMS treatment sessions on alcohol use and craving among detoxified inpatients with alcohol use disorder: a randomized sham-controlled clinical trial.
    Hoven M; Schluter RS; Schellekens AF; van Holst RJ; Goudriaan AE
    Addiction; 2023 Jan; 118(1):71-85. PubMed ID: 35971295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients.
    Weinstein A; Feldtkeller B; Feeney A; Lingford-Hughes A; Nutt D
    Addict Biol; 2003 Jun; 8(2):229-32. PubMed ID: 12850782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.